首页 | 本学科首页   官方微博 | 高级检索  
     


Long‐term use of dipeptidyl peptidase‐4 inhibitors and risk of fracture: A retrospective population‐based cohort study
Authors:Johanna H. M. Driessen MSc  Joop P. W. van den Bergh MD PhD  Hein A. W. van Onzenoort PharmD  PhD  Ronald M. A. Henry MD PhD  Hubert G. M. Leufkens PharmD PhD  Frank de Vries PharmD PhD
Affiliation:1. Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands;2. Care and Public Health Research Institute (CAPHRI), Maastricht, The Netherlands;3. Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+, Maastricht, The Netherlands;4. Department of Internal Medicine, Viecuri Medical Centre, Venlo, The Netherlands;5. Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands;6. Biomedical Research Institute, University Hasselt, Hasselt, Belgium;7. Department of Pharmacy, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands;8. Department of Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands;9. Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands;10. MRC Epidemiology Lifecourse Unit, Southampton General Hospital, Southampton, UK
Abstract:
Keywords:cohort‐study  CPRD  DPP‐4 inhibitor  fracture  type 2 diabetes mellitus
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号